Serum iron concentration and plasma oxidantantioxidant balance in patients with chronic venous insufficency

Medical Science Monitor

Volumn 17, Issue 12, 2011, Pages

  Budzyń, Magdalena ^a   Iskra, Maria ^a   Krasiński, Zbigniew ^a   Dzieciuchowicz, Lukasz ^a   Kasprzak, Magdalena ^a   Gryszczyńska, Bogna ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Chronic venous insufficiency; Malonyldialdehyde; Reactive oxygen species; Serum iron concentration; Total antioxidant capacity

Indexed keywords

IRON; MALONALDEHYDE; URIC ACID;

ANTIOXIDANT ACTIVITY; ARTICLE; BODY MASS; CHRONIC VEIN INSUFFICIENCY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; IRON BLOOD LEVEL; OXIDATIVE STRESS; URIC ACID BLOOD LEVEL;

EID: 82755168731     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.882132     Document Type: Article

References (56)

1. Elsharawy MA, Naim MM, Abdelmaguid EM, Al-Mulhim AA: Role of saphenous vein wall in the pathogenesis of primary varicose veins. Interact Cardiovasc Thorac Surg, 2007; 6: 219-24
2. Saharay M, Shields DA, Georgiannos SN et al: Endothelial activation in patients with chronic venous disease. Eur J Vasc Surg, 1998; 15: 342-49
3. Cesarone MR, Belcaro GB, Pellegrini L et al: Circulating endothelial cells in venous blood as a marker of endothelial damage in chronic venous insufficiency: improvement with Venoruton. J Cardiovasc Pharmacol Therapeut, 2006; 11: 93-98
4. Walia M, Kwan CY, Grover AK: Effects of free radicals on coronary artery. Med Princ Pract, 2003; 12: 1-9
5. Berry C, Brosnan MJ, Fennell J et al: Oxidative stress and vascular damage in hypertension. Curr Opin Nephrol Hypertens, 2001; 10: 247-55
6. Mukherjee S: The role of oxidative stress in diabetes vascular disorders. Curr Opin Lipidol, 2007; 18: 696-98
7. Thies RL, Autor AP: Reactive oxygen injury to cultured pulmonary artery endothelial cells: mediation by poly (ADP-ribose) polymerase activation causing NAD depletion and altered energy balance. Arch Biochem Biophys, 1991; 286: 353-63
8. Van Wetering S, Van Buul JD, Quik S et al: Reactive oxygen species mediate Rac-induced loss of cell-cell adhesion in primary human endothelial cells. J Cell Sci, 2002; 115: 1837-46
9. Shen HM, Pervaiz S: TNF-receptor superfamily-induced cell death: redox dependent execution. FASEB J, 2006; 20: 1589-98
10. Um HD, Orenstein JM, Wahl SM: Fas mediates apoptosis in human monocytes by a reactive oxygen intermediate depend pathway. J Immunol, 1996; 156: 3469-77
11. Takase S, Schmid-Schonbein G, Bergan JJ: Leukocyte activation in patients with venous insufficiency. J Vasc Surg, 1999; 30: 148-56
12. Smith PD: Neutrophil activation and mediators of inflammation in chronic venous insufficiency. J Vasc Res, 1999; 36: 24-36
13. Ackermann Z, Seidenbaum M, Loewenthal E, Rubinow A: Overload of iron in skin of patients with varicose vein. Possible contributing role of iron accumulation in the progression of disease. Arch Dermatol, 1988; 124: 1376-78
14. Zamboni P, Izzo M, Fogato L et al: Urine haemosiderin: a novel marker to assess the severity of chronic venous disease. J Vasc Surg, 2003; 37: 132-36
15. Maiborodin IV, Pavliuk EG, Egorov VA et al: Hemosiderin and siderophages in inguinal lymph nodes in chronic venous insufficiency of the legs. Arkhiv Patologii, 2006; 68: 23-25
16. Zamboni P, Scapoli G, Lanzara V et al: Serum iron and MMP-9 variations in limbs affected by chronic venous disease and venous leg ulcers. Dermatol Surg, 2005; 31: 644-49
17. Buege JA, Aust SD: Microsomal lipid peroxidation. Method Enzymol, 1978; 12: 302-10
18. Jentzsch AM, Bachmann H, Furst P, Biesalski HK: Improved analysis of malondialdehyde in human body fluids. Free Radical Bio Med, 1996; 20: 251-56
19. Bartosz G, Janaszewska A, Ertel D, Bartosz M: Simple determination of peroxyl radical trapping capacity. Biochem Mol Biol Int, 1998; 46: 519-28
20. Hull DS, Green K, Thomas L, Alderman N: Hydrogen peroxide-mediated corneal endothelium damage. Induction by oxygen free radicals. Invest Ophthalmol Vis Sci, 1984; 25: 1246-53
21. Bishop CT, Mirza Z, Crapo JD, Freeman BA: Free radical damage to cultured porcine aortic endothelial cells and lung fibroblasts: modulation by cultured conditions. In Vitro Cell Dev Biol, 1985; 21: 229-36
22. Michalska M, Gluba A, Dimitri PM et al: The role of polyphenols in cardiovascular disease. Med Sci Monit, 2010; 16(5): RA110-19
23. Bandyopadhyay U, Das D, Banerjee RK: Reactive oxygen species: oxidative damage and pathogenesis. Curr Sci, 1999; 77: 658-66
24. Kozka M, Krzyściak W, Pietrzycka A, Stepniewska M: Obesity and its influence on reactive oxygen species (ROS) in the blood of patients with varicose veins of the lower limbs. Przegl Lek, 2009; 66: 213-17
25. Głowinski J, Głowinski S: Generation of reactive oxygen metabolites by the varicose vein wall. Eur J Vasc Endovasc, 2002; 23: 550-55
26. Karatepe O, Unal O, Ugurlucan M et al: The impact of valvular oxidative stress on the development of venous stasis valvular oxidative stress and venous ulcers. Angiology, 2010; 61: 283-88
27. Krzyściak W, Kozka M, Kazek G, Ste{ogonek}pniewski M: Selected indicators of the antioxidant system in the blood of patients with lower limb varicose veins. Acta Angiol, 2009; 15: 10-19
28. Yeoh-Ellerton S, Stacey MC: Iron and 8-isoproatane levels in acute and chronic wounds. J Investig Dermatol, 2003; 121: 918-25
29. Chuang CC, Shiesh, Chi CH et al: Serum total antioxidant capacity reflects severity of illness in patients with severe sepsis. Crit Care, 2006; 10: R36
30. Reinisch N, Kiechl S, Mayr C et al: Association of high plasma antioxidant capacity with new lesion formation in carotid atherosclerosis: a prospective study. Eur J Clin Invest, 1998; 28: 787-92
31. Guldiken B, Demir M, Guldiken S et al: Oxidative stress and total antioxidant capacity in diabetic and nondiabetic acute ischemic stroke patients. Clin Appl Thromb-Hem, 2009; 15: 695-700
32. James TJ, Hughes MA, Cherry GW, Taylor RP: Evidence of oxidative stress in chronic venous ulcers. Wound Repair Regen, 2003; 11: 172-76
33. De Valk B, Marx JJ: Iron, atherosclerosis, and ischemic heart disease. Arch Intern Med, 1999; 159: 1542-48
34. Morrison HI, Semenciw RM, Mao Y, Wigle DT: Serum iron and risk of fatal acute myocardial infarction. Epidemiology, 1994; 5: 135-37
35. Salonen JT, Nyyssonen K, Korpela H et al: High stored iron levels are associated with excess risk of myocardial infarction in Eastern Finnish men. Circulation, 1992; 86: 803-11
36. Tynecka M: Iron and transferrin levels in the blood serum of patients with acute cerebral vascular disease depending on the clinical group and duration of stroke. Med Sci Monit, 1996; 2: 474-77
37. Kiechl S, Willeit J, Egger G et al: Body iron stores and the risk of carotid atherosclerosis. Prospective result from the Bruneck study. Circulation, 1997; 96: 3300-7
38. Howes PS, Zacharski LR, Sullivan J, Chow B: Role of stored iron in atherosclerosis. J Vasc Nurs, 2000; 18: 109-16
39. Zacharski LR, Chow B, Lavori PW et al: The iron and atherosclerosis study: a pilot study of reduction of body iron stores in atherosclerotic peripheral vascular disease. Am Heart J, 2000; 139: 337-45
40. Zamboni P, Izzo M, Tognazzo S et al: The overlapping of local iron overload and HFE mutation in venous leg ulcer pathogenesis. Free Radical Bio Med, 2006; 40: 1869-73
41. Wenk J, Foitzik A, Achterberg V et al: Selective pick-up of increased iron by deferoxamine-coupled cellulose abrogates the iron-driven induction of matrix degrading metalloproteinase 1 and lipid peroxidation in human dermal fibroblasts in vitro: a new dressing concept. J Invest Dermatol, 2001; 116: 833-39
42. Pierrie R: The influence of age upon serum iron in normal subjects. J Clin Pathol, 1952; 5: 10-15
43. Seltzer C, Mayer J: Serum iron and iron-binding capacity in adolescents. Am J Clin Nutr, 1963; 13: 354-61
44. Pinhas-Hamiel O, Newfield RS, Koren I et al: Greater prevalence of iron deficiency in overweight and obese children and adolescents. Int J Obes, 2003; 27: 416-18
45. Lecube A, Carrera A, Losada E et al: Iron deficiency in obese postmenopausal women. Obesity, 2006; 14: 1724-30
46. Al-Rafaie FN, Wickens DG, Wonke B et al: Serum non-transferrin-bound iron in beta-thalassaemia major patients treated desferrioxamine and L1. Br J Heamtol, 1992; 82: 431-36
47. Lee DH, Ding Yong L, Jacobs DR et al: Common presence of non-transferrin-bound iron among patients with type 2 diabetes. Diabetes Care, 2006; 29: 1090-95
48. Le Lan C, Loreal O, Cohen T et al: Redox active plasma iron in C282Y/ C282Y hemachromatosis. Blood, 2005; 105: 4527-31
49. de Valk B, Addicks MA, Gosriwatana I et al: Non-transferrin-bound iron in serum of hereditary heamochromatosis heterozygotes. Eur J Clin Invest, 2000; 30: 248-51
50. Van der A DL, Marx JJ, Grobbee DE et al: Non-transferrin-bound iron and risk of coronary heart disease in postmenopausal woman. Circulation, 2006; 113: 1942-49
51. Kruszewski M: The role of labile iron pool in cardiovascular diseases. Act Biochim Pol, 2004; 51: 471-80
52. Koren A, Fink D, Admoni O et al: Non-transferrin bound labile plasma iron and iron overload in Sickle Cell Disease: a comparative study between Sickle Cell Disease and b-thalassemic patients. Eur J Haematol, 2010; 84: 72-78
53. Konijn AM, Glickstein H, Vaisman B et al: The cellular labile iron pool and intracellular ferritin in K562 cells. Blood, 1999; 94: 2128-34
54. Goldman DW, Breyer RJ, Yeh D, Brockner-Ryan B: Acellular hemoglobin-mediated oxidative stress toward endothelium: a role for ferryl iron. Am J Physiol, 1998; 275: H1046-53
55. Cagiatti A, Rosi C, Franceschini M, Innocenzi D: The nature of skin pigmentation in chronic venous insufficiency: a preliminary report. Eur J Vasc Endovasc Surg, 2008; 35: 111-18
56. Alayash AI, Patel RP, Cashon RE: Redox reactions of hemoglobin and myoglobin: biological and toxicological implications. Antioxid Redox Signal, 2001; 3: 313-27